Construction of a Research and Development Facility for the Chemicals Business
First written in FY2018-Q1. 3 of 6 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022AdvancedAnnual report
「During the consolidated fiscal year, the company launched a project centered on younger employees from across its divisions and focused on further accelerating product development and strengthening its framework for collaboration with other divisions.」
The company progressed from customer-focused development based at the new R&D Center to cross-functional projects led by younger employees, aimed at accelerating development and strengthening collaboration. - FY2019Cited as achievedAnnual report
「The fiscal year was the first year of full-scale R&D activities at the new R&D Center.」
The new R&D Center completed in October 2017 is cited as marking the start of full-scale R&D activities. - FY2018AchievedAnnual report
「In October 2017, the new R&D Center was completed and the company relocated there, enabling it to make a fresh start in its development activities.」
The new R&D Center for the Chemicals business was completed in October 2017, and the relocation was completed. - FY2018-Q3AdvancedAnnual report
「The balance of property, plant and equipment and intangible assets was ¥7,622.6 million, an increase of ¥284.6 million from ¥7,338.0 million at the end of the previous consolidated fiscal year. The main factors were an increase of ¥1,678 million in leased assets due to an increase in operating lease contracts, an increase of ¥730 million in other property, plant and equipment due to the acquisition of buildings and other assets related to the R&D facility for the Chemicals business, a decrease of ¥558 million in land due to the sale of the former R&D facility, and an increase of ¥1,074 million in investment securities due to fair-value measurement and other factors.」
The acquisition of buildings and other assets related to the R&D facility for the Chemicals business progressed, and other property, plant and equipment increased by ¥730 million. The sale of the former R&D facility was also disclosed. - FY2018-Q2AdvancedAnnual report
「The balance of property, plant and equipment and intangible assets was ¥7,640.1 million, an increase of ¥302.1 million from ¥7,338.0 million at the end of the previous consolidated fiscal year. The main factors were an increase of ¥1,614 million in leased assets due to an increase in operating lease contracts, an increase of ¥572 million in other property, plant and equipment due to the construction of an R&D facility for the Chemicals business and other factors, and an increase of ¥970 million in investment securities due to fair-value measurement and other factors.」
Construction of the R&D facility for the Chemicals business continued, and other property, plant and equipment increased by ¥572 million. - FY2018-Q1First statedAnnual report
「The main factors were an increase of ¥695 million in leased assets due to an increase in operating lease contracts, an increase of ¥479 million in other property, plant and equipment due to the construction of an R&D facility for the Chemicals business and other factors, and an increase of ¥477 million in investment securities due to fair-value measurement and other factors.」
The construction of an R&D facility for the Chemicals business is described for the first time as a specific capital investment. Other property, plant and equipment increased by ¥479 million.